III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment.

This esteemed international award celebrates nurses who demonstrate extraordinary clinical skills and provide compassionate, ...

Researchers analyzed SOGI data collection practices to determine the factors associated with its prevalence across cancer centers by type and geographic area.

Two East Bay women are bringing comfort and confidence to women who've lost hair due to cancer treatment and alopecia.

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...